Table 3.
Effect sizes for outcome measures associated with PEP before and after 2-hours of treatment in children aged 5 – 17 years with acute asthma exacerbations.
Outcome measure | R2 (95% CI) Before treatment a, b | P | R2 (95% CI) After treatment c, d | P |
---|---|---|---|---|
%IOS | 1.2 (1.1, 1.4) | <0.001 | −3.3 (−10.4, 3.7) | 0.598 |
AAIRS | 1.7 (1.4, 2.0) | <0.001 | 0.4 (0.1, 0.7) | 0.01 |
%FEV1 | −12.1 (−14.9, −9.3) | <0.001 | −4.2 (−6.3, −2.0) | <0.001 |
Abbreviations: PEP, plethysmograph estimate of pulsus paradoxus; %FEV1, %-predicted forced expiratory volume in 1-second; %IOS, %-predicted airway resistance by impulse oscillometry; AAIRS, acute asthma intensity research score; CI, confidence interval.
Effect size for outcome measure across interquartile range of PEP of 34.4% to 48.1%.
Multivariable linear regression models adjusted for age, gender, race.
Effect size estimates for change of outcome measure after 2-hr of treatment across interquartile range of change of PEP (−10.7% to 1.7%) during this interval.
Multivariable linear regression models adjusted for age, gender, race, baseline AAIRS and baseline value of the outcome measure.